| Integral use of thromboelastography with platelet mapping to guide appropriate treatment, avoid complications, and improve survival of patients with coronavirus disease 2019 … T Hranjec, M Estreicher, B Rogers, L Kohler, R Solomon, S Hennessy, ... Critical Care Explorations 2 (12), e0287, 2020 | 30 | 2020 |
| Diagnosis and treatment of coagulopathy using thromboelastography with platelet mapping is associated with decreased risk of pulmonary failure in COVID-19 patients T Hranjec, M Mayhew, B Rogers, R Solomon, D Hurst, M Estreicher, ... Blood Coagulation & Fibrinolysis 34 (8), 508-516, 2023 | | 2023 |
| Platelet Inactivity-An Important Contributor To Bleeding In Kidney Transplant Patients-Can Be Evaluated Via Thromboelastography With Platelet Mapping (TEG-PM) M Mayhew, R Solomon, B Rogers, K Shaw, H LaGuardia, S Hennessy, ... AMERICAN JOURNAL OF TRANSPLANTATION 22, 73-73, 2022 | | 2022 |
| 176: Optimizing Outcomes for COVID-19 Coagulopathy Through Thromboelastography and Platelet Mapping T Hranjec, P Pepe, M Estreicher, B Rogers, R Solomon, S Hennessy, ... Critical Care Medicine 49 (1), 73, 2021 | | 2021 |
| 617: Correlation Between Thromboelastography and Standard Coagulation Tests at a Community Hospital D Fernandez, A Maldonado, L Williams, B Rogers, M Santibanez Critical Care Medicine 49 (1), 302, 2021 | | 2021 |
| Utilizing thromboelastography (TEG) to monitor coagulopathy for suspected rivaroxaban toxicity B Rogers, H Atia, L Campos, S Duverglas, D Hurst, A Augsten CLINICAL TOXICOLOGY 57 (10), 973-974, 2019 | | 2019 |
| 708: EFFECTS OF A STANDARD APPROACH TO ELEVATED INTRACRANIAL PRESSURE MANAGEMENT IN HIGH-RISK PATIENTS A Maldonado, B Rogers, L Morris Critical Care Medicine 47 (1), 334, 2019 | | 2019 |
